The Medicine Maker | The Medicine Maker

Why Europe’s CDMO Sector Must Learn to Dance with Disruption

January 14, 2026

For CDMOs, the storms of de-industrialization, Brexit, and the Biosecure Act are not existential threats but the very winds that can propel them forward.

4 min read

Drug Discovery

Schistosomiasis: The Need for a Tailored-Made Treatment for Preschoolers

About the Pediatric Praziquantel Consortium, and why a child-friendly treatment for preschool-aged children with schistosomiasis was needed

Development & Clinical

Does the Role of CDMO Need to Evolve?

In short: Yes, says Mat Minardi, Chief Scientific Officer at Sterling Pharma Solutions

Cell & Gene

Manufacturability and the Winners in Advanced Therapies

Are developers still underestimating the engineering sophistication required to scale advanced therapies in the real world? Alan Boyd discusses.

Industry News

Medable Debuts AI Agent for Automating Trial Master File Processes

New capability frees up human capital from one of the biggest labor costs in clinical research

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Christine Allen

Professor, University of Toronto; Co-founder and CEO, Intrepid Labs

View Profile

Hanns-Christian Mahler

CEO (Chief Enablement Officer) & Board Member, ten23 health

View Profile

FOYA: Celebrating Innovation in Pharma Facilities

We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.

Read the article

All the latest Medicine Maker articles.

Bioprocessing Development & Clinical Formulation Future of Pharma Technology & Manufacturing

The Future of Precision Medicine is Radiopharmaceuticals

January 12, 2026

Here’s why so many people in the industry are excited about the potential of radiopharmaceuticals for diagnosis and treatment.

5 min read

Drug Delivery Formulation Small Molecules Technology & Manufacturing Industry News

The Truth About Softgels: Phthalate-Free, Powered by Glycerin and Sorbitol

January 9, 2026

Catalent offers clarification after recent discussions raised concerns around softgels, phthalates and potential health risks

3 min read

Drug Discovery Development & Clinical Small Molecules Industry News

A Turning Point in MASH

January 8, 2026

A billion-dollar acquisition, breakthrough clinical data, and a shifting scientific paradigm are pushing MASH out of the shadows and into a new era of metabolic medicine.

3 min read

Industry News Biopharma Technology & Manufacturing

Inside 2026: The Industry’s AI Turning Point

January 7, 2026

The life sciences sector is bracing for a year when AI delivers real returns, regulators move faster, and trial operations are finally built for modern science.

6 min read

Bioprocessing Facilities & Equipment Technology & Manufacturing

Building the Future of RNA Manufacturing

January 6, 2026

Can enzyme-catalyzed processes address the limitations of traditional RNA synthesis and define the future of scalable, sustainable manufacturing of RNA therapeutics?

5 min read

Bioprocessing Supply Chain Business & Trends Biopharma

Learnings from a Scope 1 and 2 Climate-Neutral Manufacturing Facility

December 30, 2025

Merck’s climate-neutral facility shows how sustainability, supply-chain transparency, and cultural change can scale low-carbon biomanufacturing and build long-term resilience.

2 min read

Industry News Technology & Manufacturing Biopharma

Addressing the Regulatory Documentation Bottleneck to Transform Drug Approvals

December 29, 2025

Agentic AI combined with human control points creates a new paradigm for accelerating documentation while maintaining regulatory integrity.

5 min read

Drug Discovery Biopharma Research News

The Post-Pandemic Evolution of Antiviral Research

December 22, 2025

The pandemic catalyzed a transformation in antiviral R&D. From better data to open collaboration, Tetiana Matviyuk of Enamine describes how the landscape has evolved.

3 min read

Development & Clinical Biopharma Research News

New Approach Methodologies: Why the Future of Drug Development Must Be Human

December 18, 2025

NAMs aren’t just a scientific upgrade, but a moral and practical necessity. The tools are ready. The question is: does the industry have the will to use them?

3 min read

Research News Cell & Gene

Promising Data For Off-the-Shelf Gene-edited Cell Therapy

December 17, 2025

New clinical results outline patient responses to a donor-derived, gene-edited cell therapy in relapsed and refractory T-cell leukemia

2 min read

Top Stories